• prognosis
  • Despite the relatively favourable prognosis in cases of endometrial cancer, there is a necessity to evaluate clinical and prognostic utility of new molecular markers. (plos.org)
  • In terms of histopathology, it corresponds to endometrioid endometrial cancer (EEC) and usually consists of low grade and low stage tumours with favourable prognosis [ 2 ]. (plos.org)
  • clinical
  • In this study, we investigated clinical and prognostic role of miRNA-205 in endometrioid endometrial cancer. (plos.org)
  • Wilczynski M, Danielska J, Dzieniecka M, Szymanska B, Wojciechowski M, Malinowski A (2016) Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer. (plos.org)
  • Women
  • In women with endometrial hyperplasia without atypia, is the levonorgestrel-releasing intrauterine system (Mirena) or oral progestin therapy more effective in achieving complete resolution? (aafp.org)
  • In another RCT, 104 pre- and post-menopausal women with abnormal uterine bleeding and non-atypical endometrial hyperplasia were randomized to treatment with the levonorgestrel-releasing intrauterine system for three months (n = 26), oral medroxyprogesterone (Provera) for three months (n = 26), the levonorgestrel-releasing intrauterine system for six months (n = 26), or oral medroxyprogesterone for six months (n = 26). (aafp.org)
  • Complete resolution of endometrial hyperplasia was achieved by 100% of women in the levonorgestrel group, 96% in the continuous medroxyprogesterone group, and 69% in the cyclic medroxyprogesterone group. (aafp.org)
  • Endometrial cancer (EC) is one of the most common malignancies among women worldwide. (plos.org)